|
|||||
|
|
An evaluation of apalutamide for the treatment of prostate cancer |
|
| Authors: | Myrto Boukovala Nicholas Spetsieris |
| Affiliation: | Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center , Houston, TX, USA |
| Abstract: | ABSTRACT IntroductionNovel androgen signaling inhibitors are currently standard of care in the treatment of patients with prostate cancer. Second-generation androgen receptor antagonists have demonstrated efficacy in earlier disease settings, fulfilling an unmet need in the treatment of patients with advanced prostate cancer. |
| Keywords: | Androgen receptor antagonist androgen signaling inhibitor apalutamide prostate cancer treatment second generation antiandrogen |